| Catalogue Number |
Products |
CAS No. |
Assay |
| NX86886 | Ethyl 3-oxoheptanoate | 7737-62-4 | 95% |
| NX86887 | 2-amino-N-(4-methoxyphenyl)benzamide | 20878-54-0 | 95% |
| NX86888 | ethyl (2,3-dioxo-2,3-dihydro-1H-indol-1-yl)acetate | 41042-21-1 | 95% |
| NX86889 | thiazol-2-ylhydrazine | 30216-51-4 | 95% |
| NX86890 | 1-(4-methoxybenzyl)-1H-indole-2,3-dione | 31541-32-9 | 95% |
| NX86891 | 2,3-Dihydro-6-hydroxybenzofuran | 23681-89-2 | 95% |
| NX86892 | 2-hydroxymethyl-5-benzyloxypyridine | 59781-11-2 | 95% |
| NX86893 | N-Boc-4-aminobenzyl alcohol | 144072-29-7 | 95% |
| NX86894 | 2-(2-bromoethyl)pyridine | 39232-04-7 | 95% |
| NX86895 | 3-(2-methoxyphenyl)-propionic acid chloride | 22955-75-5 | 95% |
| NX86896 | 2-hydrazino-6-fluoro-1,3-benzothiazole | 78364-55-3 | 95% |
| NX86897 | 1-hydrazino-isoquinoline | 15793-94-9 | 95% |
| NX86898 | 2-cyclopropylethyl bromide | 36982-56-6 | 95% |
| NX86899 | 4-chlorocarbonyl-piperidine-1-carboxylic acid tert-butyl ester | 280115-99-3 | 95% |
| NX86900 | 5-methyl-1H-Pyrazol-3-ol | 145091-87-8 | 95% |
| NX86901 | 1-(ethoxycarbonyl)-1-(p-chlorobenzyl)-2-propanone | 36600-72-3 | 95% |
| NX86902 | 3-nitro-1H-pyrazole-5-carboxylic acid | 925646-13-5 | 95% |
| NX86903 | 2,3,4,5-tetrahydro-benzo[b][1,4]thiazepine | 40358-33-6 | 95% |
| NX86904 | 2-amino-N-(n-butyl)benzamide | 10494-82-3 | 95% |
| NX86905 | 4-benzyl-benzoyl chloride | 22746-83-4 | 95% |
| NX86906 | 2-(4-methoxyphenyl)acetoacetic acid ethyl este | 5219-08-9 | 95% |
| NX86907 | 1-hexylisatin | 56932-61-7 | 95% |
| NX86908 | 1-pentyl-isatin | 4290-90-8 | 95% |
| NX86909 | 1,8-bis(bromomethyl)anthracene | 34824-21-0 | 95% |
| NX86910 | 2,3-Dihydro-7-hydroxy-4H-1-benzopyran | 57052-72-9 | 95% |
| NX86911 | 4-phenylpyridin-2-one | 19006-81-6 | 95% |
| NX86912 | 4,6-dimethyl-dibenzofuran | 1136-77-2 | 95% |
| NX86913 | 2-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one | 27420-41-3 | 95% |
| NX86914 | 2-(4-Bromophenyl)propanoic acid | 53086-53-6 | 95% |
| NX86918 | N-(5-hydroxy-2-phenoxyphenyl)Benzenesulfonamide | 123664-83-5 | 95% |